Mylan Inc.’s share price up, to acquire Abbott Laboratories in an all-stock $5.3 billion deal
July 15, 2014 7:39 am
Mylan Inc. announced in a statement that it is to acquire the generic-drug Abbott Laboratories in a “spinversion” all-stock deal estimated at $5.3 billion, which will allow both companies to be domiciled outside the US, lowering tax rates. According to the terms of the purchase that were disclosed, 21% of the new company will be […] Read more